http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27665552

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 2379
issn 1527-7755
0732-183X
issueIdentifier 20
pageRange 2372-2379
publicationName Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage 2372
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_090e0767e1e60f4b08bad3e59c3e7687
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0a199f7489dc7a098533dfdfd8df87c3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3cc02304744a3345654cf0afba16ff55
bibliographicCitation Appel BE, Chen L, Buxton AB, Hutchison RE, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL. Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group. J Clin Oncol. 2016 Jul 10;34(20):2372–9. PMID: 27185849; PMCID: PMC4981978.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3af6819dd0b6796d46bbc39b6e6c40ff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3773fd0dacd29fe8fd3ef0086250007c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a955345de8df720f1e8d73be107556d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a6f2ce41938b1f09a9bd68df4ce4b6a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bea8b298b5490d0f3f2f2924495ea3d2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57e492f18ba22a0e0019f79c09808917
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa974a95ab5299a14a3ad6f63fda9ee3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30863cfdb7ef3c2d7166a887a4fee9cc
date 2016-07-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/27185849
https://doi.org/10.1200/jco.2015.65.3469
https://pubmed.ncbi.nlm.nih.gov/PMC4981978
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
https://portal.issn.org/resource/ISSN/1527-7755
https://portal.issn.org/resource/ISSN/0732-183X
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D006689Q000628
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D002675
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D006689Q000401
http://id.nlm.nih.gov/mesh/D003131
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145

Showing number of triples: 1 to 57 of 57.